ABOUT THIS EPISODE
Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay its onset.
The GameChanger
Several studies suggest a delay in onset of dementia with the recombinant shingles vaccine.
Host
Jen Moulton, BSPharm
President, CEimpact
Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
The recombinant shingles vaccine is associated with lower risk of dementia
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe dementia's epidemiology and the significance of preventive interventions.
2. Discuss the strengths, weaknesses, and outcomes of the study.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-246-H01-P
Initial release date: 08/19/2024
Expiration date: 08/19/2025
Additional CPE details can be found here.
SHOW NOTES 🔗
TRANSCRIPT 🔗
00:00:01.241 --> 00:00:04.610
Hi, health Mart Pharmacists From your education partner, ce Impact.
00:00:04.610 --> 00:00:05.833
This is Game Changers.
00:00:05.833 --> 00:00:16.163
I'm your host, jen Moulton, and each week we have a conversation on a hot clinical topic that will keep you current in practice and position you as a resource for prescribers and patients.
00:00:16.163 --> 00:00:17.507
Thanks for listening in.
00:00:17.507 --> 00:00:19.341
Did you know?
00:00:19.341 --> 00:00:28.125
The CDC now says that dementia is the sixth leading cause of death overall and the fifth leading cause of death for adults over age 65.
00:00:28.125 --> 00:00:32.533
It continues to rise and devastate patients and their families.
00:00:33.259 --> 00:00:37.512
There have been few interventions that have shown to prevent dementia and Alzheimer's disease.
00:00:37.512 --> 00:00:41.593
However, there is a new study showing a little bit of hope.
00:00:41.593 --> 00:00:46.469
So I say a little bit of hope, and we are going to gleam onto anything that shows a little bit of hope.
00:00:46.469 --> 00:00:50.362
So, surprisingly, it has to do with the shingles vaccine.
00:00:50.362 --> 00:00:52.771
So we're going to talk about that today.
00:00:52.771 --> 00:00:56.281
On this Game Changers and I've been excited about this topic for a while.
00:00:56.281 --> 00:00:59.329
We've had it on our list, so I'm happy to get into it.
00:00:59.329 --> 00:01:03.323
So here to talk with us today is our resident expert, Geoff Wall.
00:01:03.323 --> 00:01:08.311
Dr Wall, what can you tell us about why this information is important right now?
00:01:09.313 --> 00:01:09.834
Yeah, thanks, jen.
00:01:09.834 --> 00:01:32.656
Yeah, this is a kind of interesting study and, of course, we don't want to overplay things, but I think this is, I think, the best study to date that suggests that there probably is a link between zoster and the development of at least some types of dementia and that, yeah, maybe, you know, being vaccinated might be helpful.
00:01:32.656 --> 00:01:37.430
So this is a study that's garnered a lot of lay media attention, like all things that have to do with alzheimer's.
00:01:37.430 --> 00:01:46.870
I think you know a lot of lay media outlets kind of pick this up and I think that's why we chose this for game changers, because I suspect that a lot of pharmacists and providers are going to get questions about this stuff.
00:01:46.870 --> 00:01:51.167
So, you know again, you know a quick, you know review of of of zoster.
00:01:51.307 --> 00:02:15.268
You know again, we, we, you know know that that you know the zoster vaccine, especially the recombinant zoster vaccine that has been out since 2017, is unbelievably effective at reducing not only the incidence of shingles but, I think, more importantly, the incidence of posteropetic neuralgia, which is really the long-term issue that to date we know is associated with shingles.
00:02:15.268 --> 00:02:22.972
It's actually recommended by ACIP for, basically, you know, all adults over age 50 or 60, certainly 60.
00:02:22.972 --> 00:02:28.848
And then you know there's evidence, certainly down to 50, that that that Shingrix should be given to all these patients.
00:02:28.848 --> 00:02:31.782
If you've ever had shingles, you know how painful it is.
00:02:31.782 --> 00:02:34.329
I've known a lot of people who've had it.
00:02:34.329 --> 00:02:37.245
They've compared it to some of the most painful stuff they've ever had in their life.
00:02:37.245 --> 00:02:44.150
And then unfortunately, as I said, there's a percentage of patients who even after the lesions crust over and go away.
00:02:44.150 --> 00:02:51.282
They still have post-repetitonuralgia which is very difficult to treat.
00:02:51.282 --> 00:02:53.051
And now you're on all sorts of medications for neuropathic pain and stuff like that.
00:02:53.072 --> 00:03:00.193
So I think that's the you know, you know taking everything aside, obviously the benefit of shingles vaccine just in preventing shingles is a pretty big deal.
00:03:00.193 --> 00:03:12.729
But now this study comes out and kind of talks about, you know, what would be the role of shingles vaccine, you know, as their association between that and decreased risk of dementia, as you point out, jen, you know it's again it's.
00:03:12.729 --> 00:03:19.429
It's a huge cause of death and, if you know, alzheimer's disease is the one we most think of the most commonly.
00:03:19.429 --> 00:03:22.368
But there are actually numerous kinds of dementia.
00:03:22.368 --> 00:03:34.750
There's, you know, frontal lobe dementia, there's Lewy body dementia, there's all sorts of stuff and they all really kind of have one thing in common is that we really don't have good treatments for them and even prevention is really kind of iffy.
00:03:34.750 --> 00:03:37.805
So, as you point out, it's a leading cause of death.
00:03:38.006 --> 00:03:40.393
It's also very, very expensive.
00:03:40.393 --> 00:03:45.507
It costs economies globally 1.3 trillion that's with the T?
00:03:45.507 --> 00:03:52.490
U S dollars, and of course, the vast, vast majority of that is cost provided to caregivers, right?
00:03:52.490 --> 00:03:55.689
So either family members, close friends or nursing homes and stuff like that.
00:03:55.689 --> 00:04:03.252
And some studies suggest that with advanced dementia, that that patients require at least five hours of direct care and supervision a day.
00:04:03.252 --> 00:04:05.186
So you know, you know again, know again.
00:04:05.186 --> 00:04:12.305
That's a huge cost, that's a huge burden on the healthcare system and it's a huge burden on family members, both emotionally and financially.
00:04:12.305 --> 00:04:20.886
Women are disproportionately affected by dementia, as I think we know, probably because a lot of it is that they live longer than men and they live long enough to develop dementia.
00:04:20.886 --> 00:04:24.153
But still it's something that we've seen.
00:04:26.639 --> 00:04:35.555
As far as treatments, you know, we in past Game Changers, we've talked about some of the new anti-Tau monoclonal antibodies that will come out and I have not been a big, I have not been particularly impressed.
00:04:35.555 --> 00:04:45.086
I think the evidence suggests that it may slow down the progression of Alzheimer's, but at the risk of the development of head bleeds, which isn't good.
00:04:45.086 --> 00:04:51.552
As well as the enormous expense associated with the drug, somewhere in the order of about $50,000 a year.
00:04:51.552 --> 00:04:54.004
Also, the cost.
00:04:54.004 --> 00:04:55.086
That's just direct costs.
00:04:55.086 --> 00:04:59.903
We don't talk about the indirect costs of frequent MRIs to look for head bleeds and stuff.
00:04:59.903 --> 00:05:06.228
So I mean, I think there's a reason why FDA was kind of on the fence about approving those medications, you know.
00:05:06.228 --> 00:05:18.627
And of course we've got the old standbys like denepazil and memantine, which, again, you know, really, you know may slow the progression of dementia but really don't actually prevent things like going into the nursing home.
00:05:18.627 --> 00:05:23.401
You know, they may slow some of the numbers associated with dementia, but that's really about it.
00:05:23.502 --> 00:05:35.721
So, you know, instead of treatment, people have turned to prevention and again we don't have any really good you know evidence that drugs of any sort actually slow or reduce the risk of cognitive decline.
00:05:35.721 --> 00:05:39.350
So basically, it's all the healthy stuff that you should do, right.
00:05:39.350 --> 00:05:50.060
You should, you know, be physically active, don't smoke, don't drink excess alcohol, eat a healthy diet, maintain normal blood pressure, because one of the most common causes of dementia is hypertension.
00:05:50.060 --> 00:05:54.370
When people get, you know, small vascular dementia and stuff like that.
00:05:54.370 --> 00:06:02.444
Probably the biggest studies that have shown prevention is basically keep yourself active.
00:06:02.444 --> 00:06:12.439
People who lay around and watch television all day long are, frankly, more likely to develop dementia than people who keep their brains active through reading, puzzles etc, etc.
00:06:12.439 --> 00:06:20.935
And again, a lot of our apps out there are trying to really kind of push that and maybe they're not so bad as long as you're not paying a lot of money for them.
00:06:20.935 --> 00:06:25.937
But the bottom line is keep your brain going and it just decreases the risk of dementia.
00:06:26.024 --> 00:06:29.773
So there are no drugs that have been associated with the increase of dementia.
00:06:29.773 --> 00:06:33.329
So you know anything that that is a drug or a vaccine that may do.
00:06:33.329 --> 00:06:43.978
That is going to generate a lot of information and we've known for decades or at least associated for decades that that zoster may be associated with dementia.
00:06:43.978 --> 00:07:03.831
If this has not been proven, obviously, but the association between zoster directly causing dementia has been postulated for decades now and previous studies have, you know, taken a look at this and said you know, yeah, gee, it seems that people who are vaccinated seem to be at lower risk.
00:07:03.831 --> 00:07:17.891
The problem with all these studies, of course, is there's bias, because they've studied basically people who are vaccinated versus people who weren't vaccinated, and people who are vaccinated are just more likely to live healthy lifestyles, they're more likely to have a better insurance.
00:07:18.033 --> 00:07:21.406
They're more likely to have a higher socioeconomic status, et cetera, et cetera.
00:07:21.406 --> 00:07:30.279
So you know the association was there, but it was always someone suspect because of the risk of bias.
00:07:30.279 --> 00:07:36.298
So the authors of this study and we've got a link in the show notes did something pretty cool.
00:07:36.298 --> 00:07:38.555
I wish I would have thought of it myself, to be honest with you.
00:07:38.555 --> 00:07:46.290
And they said well, you know, we have the opportunity to do a natural experiment here because, as we all know, there's been two shingles vaccines out in the last decade.
00:07:46.290 --> 00:07:48.464
The first was Zostavax and Zostavax all know there's been two shingles vaccines out in the last decade.
00:07:48.464 --> 00:07:55.519
The first was Zostavax and Zostavax was used pretty extensively.
00:07:55.519 --> 00:08:03.365
The problem with Zostavax was that it was a live vaccine so, again, a lot of people couldn't take it who couldn't take live vaccines and it wasn't that effective.
00:08:03.365 --> 00:08:07.697
It didn't do a very good job at preventing shingles or post-herpetic neuralgia.
00:08:07.697 --> 00:08:08.177
That effective.
00:08:08.177 --> 00:08:10.745
It didn't do a very good job at preventing shingles or post-herpetic neuralgia.
00:08:10.745 --> 00:08:28.807
And so when the recombinant vaccine came out in 2017, shingrix, it was far more effective, more like 85 to 90% effective in the first five years of preventing shingles and post-herpetic neuralgia and, as you might imagine, as soon as that vaccine became available, pretty much everybody who could switch did.
00:08:28.807 --> 00:08:46.908
And so there's this kind of natural experiment they could do where they would look at patients who got the shingles vaccine before that 2017 release of Shingrix and then a period after that where almost everybody was on Shingrix.
00:08:46.908 --> 00:08:58.565
So you know again, you know, give these guys props for kind of thinking ahead and saying you know, this is a way to kind of, you know, take a look at this and minimize that healthy patient bias sort of thing.
00:08:58.684 --> 00:09:00.913
So this was a large database study.
00:09:00.913 --> 00:09:04.610
They used the Trinic X collaborative network database.
00:09:04.610 --> 00:09:23.548
62 healthcare organizations, health hospitals, primary care specialists over 100 million patients are involved with this, and the healthcare organizations basically just supply de-identified healthcare information, including demographics, diagnoses, medications and a wide variety of other stuff.
00:09:23.548 --> 00:09:30.927
And so the authors basically took this data from the Trinet X database to try and figure out kind of this answer.
00:09:30.927 --> 00:09:34.254
And so you know what they did.
00:09:34.254 --> 00:09:43.562
Basically was they compared patients who got the shingles vaccine or the Zostavax vaccine from 2014 to 2017.
00:09:43.562 --> 00:09:50.038
And then they looked at patients who received the shingress vaccine from 2017 to 2020.
00:09:50.038 --> 00:09:55.918
To be in the study, they basically looked at older patients and that was really about it.
00:09:55.918 --> 00:09:59.754
So I mean, there wasn't a lot of exclusion criteria, anything like that.
00:10:00.375 --> 00:10:05.876
Then they did, as you might imagine, with these kind of studies they had to do a propensity match score.
00:10:05.876 --> 00:10:12.563
So what they did was they took a look at patients and tried to match them as closely as possible for a pretty big number 60 covariates.
00:10:12.563 --> 00:10:37.479
So they really tried to minimize bias by matching patients, again on a scale of 60 covariates, including comorbidities, things like diabetes, a history of previous herpes infection, history of influenza, vaccine, age, socioeconomic factors, race, marital status, you know, etc.
00:10:37.479 --> 00:10:38.386
Etc.
00:10:38.386 --> 00:10:38.567
Etc.
00:10:38.567 --> 00:10:45.995
We won't spend a lot of time talking a lot about that, but basically, you know, trying to match these people together to kind of figure that out.
00:10:45.995 --> 00:11:00.687
In the end they had a matching number of patients of 103,000 individuals who received a first vaccination of Shingrix between 2017 and 2020.
00:11:00.707 --> 00:11:07.845
And then again they propensity matched those two patients who received Zostavax from 2014 to 2017.
00:11:07.845 --> 00:11:11.655
And they followed these patients forward in time about four years.
00:11:11.655 --> 00:11:16.855
So again, that's why the paper was just published, because they followed from 2017 to 2020, basically.
00:11:16.855 --> 00:11:21.813
So now we're kind of four years out, basically as far as demographic data on these patients.
00:11:21.813 --> 00:11:26.056
The patients were in their 50s and 60s, as you might imagine.
00:11:26.056 --> 00:11:33.934
Again, the follow-up was about four years, the majority of patients were females, and then that was really about it.
00:11:33.934 --> 00:11:58.198
I mean, there wasn't a whole lot of differences between the groups and what they basically found was that there was a statistically significant decrease in the development of dementia between patients who received Shingrix compared to those who received Zostavax and so, and that was a hazard ratio of 0.83, and the 95% COPS interval did not cross one.
00:11:58.198 --> 00:11:59.871
So you know, it was statistically significant.
00:12:00.725 --> 00:12:15.210
When they did a deep dive in the data, it looked like as far as preventing, uh, alzheimer's, and only minimally did that, and what it actually did was it translated into 17% more time lived diagnosis free.
00:12:15.210 --> 00:12:25.269
So in other words, um, uh, you know, when they match patients who ended up getting dementia, the actual number of patients who got dementia between Shingrix and Octobass really wasn't that much different.
00:12:25.269 --> 00:12:28.749
It was a little bit lower in the Shingrix group, but that didn't reach statistical significance.
00:12:28.749 --> 00:12:45.488
What did reach statistical significance was the amount of time lived without the diagnosis put in the chart of them having dementia, and that translated into about six months, about 164 days among those who were affected with dementia.
00:12:45.488 --> 00:12:52.046
So you know, does the Shingles vaccine prevent dementia or is it associated with prevention dementia?
00:12:52.046 --> 00:13:00.393
Maybe minimally, but what it does seem to do is prevent the development of dementia, or at least the worsening of dementia over time.
00:13:00.393 --> 00:13:09.653
This was true across all types of dementia, except for Lewy body and frontal temporal dementia, which again kind of makes sense because those types of dementia are different from Alzheimer's.
00:13:09.653 --> 00:13:12.106
So kind of makes sense because those types of dementia are different from Alzheimer's.
00:13:12.106 --> 00:13:13.068
So that kind of makes sense.
00:13:14.371 --> 00:13:19.495
Those vaccinated after 2017 were less likely to have a herpes zoster vaccine or infection.
00:13:19.495 --> 00:13:23.811
Big surprise, because again we know that Shingrix is more effective than Zostafax was.
00:13:23.811 --> 00:13:26.538
There was no difference in all cause mortality.
00:13:26.538 --> 00:13:33.708
But when they did all these other covariates, it was basically found in all the different covariate groups basically.
00:13:33.708 --> 00:13:40.636
So when adjusting for socioeconomic factors age, gender, race, everything else it found that they were similar.
00:13:40.636 --> 00:13:50.648
And interestingly, one of the covariates they looked at was influenza vaccination, because again, is this just a vaccination effect or is it specifically targeted disaster.
00:13:50.648 --> 00:14:01.705
And they found again that shingles vaccines both of them were associated with a lower risk of dementia compared to patients who either received the influenza vaccine or the Tdap vaccines.
00:14:01.705 --> 00:14:06.717
And again the numbers were very similar, kind of across the board about 20% decrease.
00:14:06.845 --> 00:14:12.135
So it looks like it isn't vaccines in and of themselves that prevent dementia.
00:14:12.135 --> 00:14:17.153
It looks or may prevent dementia or delayed the onset of dementia.
00:14:17.153 --> 00:14:23.650
It looks like it's actually specific to shingles vaccine.
00:14:23.650 --> 00:14:24.653
So that's kind of interesting.
00:14:24.653 --> 00:14:30.229
So you know, again there's been a lot of experts who've kind of weighed in on this.
00:14:30.229 --> 00:14:38.472
I was kind of reading some of the editorials in this and some of the other kind of big medical websites and again, everyone's kind of cautious.
00:14:38.472 --> 00:14:42.917
No one is probably going to get the Zoster vaccine to prevent dementia, right.
00:14:42.917 --> 00:14:46.730
It's like, well, I don't really care about getting shingles, I just don't want to get dementia.
00:14:46.730 --> 00:14:48.552
That's probably not going to happen, right?
00:14:48.552 --> 00:15:03.477
But it does suggest that if you are on the fence about getting the shingles vaccine and I really don't know why anybody would be, you know, this may be an added benefit that at least we're going.
00:15:03.498 --> 00:15:06.118
You know this is the best data we're probably ever going to get on this.
00:15:06.118 --> 00:15:08.966
There's never going to be a randomized control trial on this, obviously.
00:15:08.966 --> 00:15:19.400
So this is really probably the best data we're going to get, suggesting that there may be an added benefit to receiving Shingrix in addition to just preventing shingles.
00:15:19.400 --> 00:15:23.176
You know, as anyone who's received the vaccine will tell you, it's kind of painful.
00:15:23.176 --> 00:15:25.472
Some people are kind of nervous to get that because of it.
00:15:26.226 --> 00:15:33.778
I get that and I totally understand, but in my opinion this is just one more reason really to think about getting the Zoster vaccine.
00:15:34.085 --> 00:15:35.750
So pretty simple, pretty easy.
00:15:35.750 --> 00:15:38.056
You know, yeah, I mean I totally agree with you.
00:15:38.056 --> 00:15:43.378
And when you said I don't know why anybody wouldn't, it's because they're I mean, they're painful.
00:15:43.378 --> 00:15:46.488
Well, right, like you know, there's a lot of hesitation.
00:15:46.488 --> 00:15:51.472
I think about it and I think people put it off, and you know I was going to talk a little bit about that.
00:15:51.472 --> 00:15:54.615
In terms of vaccine hesitancy, I think this is huge.
00:15:54.615 --> 00:15:57.698
I mean, this is everybody's scared of getting dementia.
00:15:57.698 --> 00:16:08.052
You know we're all playing those games on our phones and you know, reading about it constantly and looking for, you know, what's going to be the breakthrough that you know prevents that, because none of us have that.
00:16:08.052 --> 00:16:21.753
So I think, in terms of vaccine hesitancy, this is a huge thing in our arsenal where we can say there has been evidence that it prolongs dementia and maybe that's the thing that tips people over the edge to say, okay, yeah, I'm going to get it.
00:16:21.753 --> 00:16:29.047
So I think that's, I think it's really important information for pharmacists to have and to utilize that in some of your conversations.
00:16:29.427 --> 00:16:35.094
Yeah, no, I agree, and you know, as everybody knows, you know, vaccine hesitancy is kind of at an all-time high.
00:16:35.094 --> 00:16:39.493
You know we could spend you know hours talking about why that is.
00:16:39.493 --> 00:16:45.253
But you know, I think that you're right, that I think that there is some hesitancy.
00:16:45.253 --> 00:16:53.033
I personally know I'm kind of of the age where I know people who are getting this or are thinking about getting it, and probably you know.
00:16:53.173 --> 00:16:56.908
You know, like you, jen, when anyone ever asks you, yeah, well, absolutely you should get it.
00:16:56.908 --> 00:16:57.552
No doubt about it.
00:16:57.552 --> 00:17:10.415
You know, um, there we have very few vaccines that are 90% effective, um, over the course of at least five years, and so, um, you know, and and again I mean people who haven't had shingles don't understand how painful it is.
00:17:10.415 --> 00:17:12.117
I mean it is, you know, it is like I said.
00:17:12.117 --> 00:17:16.523
I've had friends who have just said, you know, it's the worst pain they've ever had in their life, and these are women who have had babies.
00:17:16.523 --> 00:17:19.013
So it's like, okay, good to know.
00:17:19.305 --> 00:17:20.246
You know, yeah, I'm not.
00:17:20.246 --> 00:17:23.288
You know I'll take a little bit of pain in two shots to deal with that.
00:17:23.288 --> 00:17:25.990
And even coverage.
00:17:25.990 --> 00:17:31.414
I've not heard of too many insurances that don't pay for the shingles vaccine.
00:17:31.414 --> 00:17:34.517
I think you know this is, you know it's pretty universally covered.
00:17:34.517 --> 00:17:40.442
So really, the you know the hesitancy comes from, gee, you know, I'm just not sure I, you know, want to get another vaccine.
00:17:40.442 --> 00:17:41.021
Gee, I've heard it.
00:17:41.021 --> 00:17:43.223
My friends tell me it really hurts, et cetera, et cetera.
00:17:43.223 --> 00:18:03.630
And yeah, if this piece of information says, okay, look, you know, if not getting shingles isn't enough for you, if that isn't enough on the table to consider it, you know, perhaps the you know the fact that you know, at a minimum, while it may not prevent dementia, you know how would you like to live another six months without that diagnosis.
00:18:03.630 --> 00:18:07.286
You know, and that's really what this study kind of showed, yeah, yeah, absolutely.
00:18:07.346 --> 00:18:08.385
I think it's super powerful.
00:18:08.385 --> 00:18:12.469
If Jake were here, he would talk about the health equity component.
00:18:12.469 --> 00:18:15.230
He'll be proud of us that we're going to address that.
00:18:15.230 --> 00:18:20.773
But you know I think you mentioned that that there wasn't, you know, a difference across socioeconomic.
00:18:20.773 --> 00:18:27.097
But again, I think it's just the vaccine hesitancy and just asking the question you know, are you up to date on your vaccines?
00:18:27.097 --> 00:18:28.097
This is where you should be.
00:18:28.097 --> 00:18:30.779
These are the ACIP recommended vaccines at your age.
00:18:30.779 --> 00:18:32.740
You know, have you gotten them?
00:18:33.261 --> 00:18:36.467
Let's you know, let's make an impact on that in pharmacy.
00:18:36.467 --> 00:18:39.417
I think that is such a huge opportunity for us.
00:18:39.417 --> 00:18:45.094
We can ask that question every month when they come in to get medications refunded.
00:18:45.193 --> 00:18:48.188
I think that's the key is that you know there are a lot of you know.
00:18:48.188 --> 00:18:52.955
Again, I'm I would like to think that most primary care docs are addressing this with with their patients.
00:18:52.955 --> 00:18:59.976
But but yeah, as you point out, you know they get a once a year, once every six months sort of ability to do that.
00:18:59.976 --> 00:19:07.794
But yeah, you know, every time you come in and go, you know, hey, you know, you know, I noticed that you're 55 and you've not, according to our records, you haven't received this.
00:19:07.794 --> 00:19:08.795
Would you be interested?
00:19:08.795 --> 00:19:14.829
You know, and eventually, I think there are going to be a cohort of patients are like, ok, ok, you know, this is the sixth time you've asked me.
00:19:14.829 --> 00:19:22.438
I get it, let's, let's go ahead and do that, you know, and yeah, I mean, you know, I think if you can capture even 10, 15 percent of those patients, it's going to make a difference.
00:19:22.505 --> 00:19:23.925
Yeah, yeah, absolutely.
00:19:23.925 --> 00:19:25.866
Well, any last parting words?
00:19:26.227 --> 00:19:29.709
No, I mean, I think we're, I think we're going to see more and more of this.
00:19:29.709 --> 00:19:33.471
You know, again, the holy grail in this is actually a vaccine to prevent.
00:19:33.471 --> 00:19:34.811
You know, and there's the.
00:19:34.811 --> 00:19:42.336
You know Alzheimer's and they've looked at, you know, vaccines against, you know that that attack tau, or vaccines that attack amyloid.
00:19:42.336 --> 00:19:46.758
I don't know if, if you know if that's ever going to get off the ground.
00:19:46.758 --> 00:19:48.618
I mean, they've been trying to do that for 25 years.
00:19:48.618 --> 00:19:49.239
You know.
00:19:49.259 --> 00:20:02.234
The sad fact is is, I'm not sure what you know, barring some gigantic breakthrough uh, that you know something, that you know a way to approach Alzheimer's that's just completely different than what we think about the pathophysiology.
00:20:02.234 --> 00:20:08.750
Now, I'm not sure we're ever going to come up with with a treatment that significantly stops the progression of cognitive decline.
00:20:08.750 --> 00:20:11.972
Um, and so prevention is going to be the way to go here.
00:20:11.972 --> 00:20:26.775
And, and you know, again, I think, I think that we are a long, long ways away from saying, okay, well, grandma's starting to forget stuff, let's go and start her on this med so that she doesn't get any worse.
00:20:26.775 --> 00:20:27.478
Yeah, we're a long ways from that.
00:20:27.478 --> 00:20:32.434
And so anything we can do to delay or prevent, you know that's not, you know, drug related.
00:20:32.434 --> 00:20:33.509
I think is huge.
00:20:34.009 --> 00:20:35.194
Yeah, yeah, absolutely.
00:20:35.194 --> 00:20:37.372
Well, this is a huge step towards that.
00:20:37.854 --> 00:20:38.074
I agree.
00:20:39.586 --> 00:20:40.832
And has other benefits as well.
00:20:40.832 --> 00:20:42.068
So that's the bonus.
00:20:42.068 --> 00:20:44.450
Yep, okay, well, thank you, Geoff.
00:20:44.450 --> 00:20:45.730
Thank you so much, dr Wall.
00:20:45.730 --> 00:20:47.386
I appreciate you being here with us this week.
00:20:47.386 --> 00:20:49.509
Appreciate you being here with us this week, and that's it for this week.
00:20:49.509 --> 00:20:53.737
Be sure to log in to Health Mart University to claim your CE credit for this episode.
00:20:53.737 --> 00:20:56.279
As always, have a great week and keep learning.
00:20:56.279 --> 00:21:10.828
We'll talk to you next week.